Summary

The field of software-enhanced drugs and prescription digital therapeutics is rapidly advancing, with significant attention drawn to FDA guidance.

Clinical research demonstrates the potential of these digital tools across various conditions, including breast cancer, depression, migraine, and schizophrenia.

Multiple publications detail ongoing and planned clinical trials, such as the Phase 3 study for CT-152 in Major Depressive Disorder and investigations into episodic migraine treatments.

Furthermore, academic work analyzes the substantial health care resource utilization and economic burden associated with chronic conditions like migraine.

Title

Click Therapeutics - Where Science Meets Software

Description

We combine neuroscience with the power of software to create patient-centric digital treatments. Discover our prescription digital therapeutics and software-enhanced drug therapies.

Keywords

therapeutics, software, click, prescription, migraine, drugs, posters, presentations, therapeutic, care, treatments, study, cancer, david, klein, founder, retrospective

Downstreams

linkedin.com, instagram.com, facebook.com, x.com

NS Lookup

A 152.42.154.197

Dates

Created 2026-09-20

Updated 2026-09-29

Summarized 2026-09-29